about
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the ful...
Read More
12.71
-0.04
(-0.31%)
104.2K
XNAS Volume
XNAS 30 Jul, 2025 1:45 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Septerna Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..